Ypsomed Holding AG header image

Ypsomed Holding AG

YPSN

Equity

ISIN CH0019396990 / Valor 1939699

SIX Swiss Exchange (2026-05-22)
CHF 340.00+3.91%

Ypsomed Holding AG
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

Ypsomed Holding AG is a Swiss company specializing in the development and production of injection and infusion systems for self-medication, primarily serving the pharmaceutical and biotechnology sectors. The company operates through two main divisions: Ypsomed Delivery Systems (YDS) and mylife Diabetescare. YDS provides a wide array of technologies and services designed to ensure reliable and user-friendly injection systems, catering to companies that develop and market injectable therapies. Meanwhile, the mylife Diabetescare brand offers a comprehensive range of products and services aimed at simplifying self-treatment for individuals with diabetes, enhancing their ability to manage their condition discreetly and effectively. Ypsomed's focus on innovation and user-centric design positions it as a key player in the medical technology industry, particularly in the field of self-administered drug delivery solutions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-8.11%1Y
45.6%3Y
146%5Y

Performance

32.9%1Y
31.8%3Y
31.2%5Y

Volatility

Market cap

5699 M

Market cap (USD)

Daily traded volume (Shares)

22,881

Daily traded volume (Shares)

1 day high/low

340 / 328

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.50
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.50
Khiem Tran
Switzerland, 02 Nov 2025
star star star star star
There is potential but it’s right now lagging.
Khiem Tran
Switzerland, 31 Oct 2025
star star star star star
Ypsomed is under Track because of the high potential innovation and R&D.

EQUITIES OF THE SAME SECTOR

Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.73%USD 65.49
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%EUR 92.30
Summit Therapeutics Inc
Summit Therapeutics Inc Summit Therapeutics Inc Valor: 56903013
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.87%USD 16.62
Revolution Medicines Inc
Revolution Medicines Inc Revolution Medicines Inc Valor: 52143299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.41%USD 151.56
Alignment Healthcare Inc
Alignment Healthcare Inc Alignment Healthcare Inc Valor: 110387702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.12%USD 16.35
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.15%USD 59.46
CVS Health Corp
CVS Health Corp CVS Health Corp Valor: 548525
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.06%USD 93.26
Stryker Corp
Stryker Corp Stryker Corp Valor: 974330
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%USD 316.48
FibroGen Inc
FibroGen Inc FibroGen Inc Valor: 25953994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.72%USD 6.99
Tilray Brands Inc
Tilray Brands Inc Tilray Brands Inc Valor: 42386407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.11%USD 5.29